HRP20030783B1 - Pyrazole derivatives for treating hiv - Google Patents

Pyrazole derivatives for treating hiv

Info

Publication number: HRP20030783B1
Authority: HR; Croatia
Prior art keywords: alkyl; optionally substituted; cycloalkyl; alkylene; heteroatoms
Prior art date: 2001-04-10

Application number

HR20030783A

Other languages

English (en)

Croatian (hr)

Inventor

Howard Jones Lyn

Eric Mowbray Charles

Anthony Price David

Duncan Selby Matthew

Anthony Stupple Paul

Original Assignee

Pfizer Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-04-10

Filing date

2003-09-29

Publication date

2011-11-30

2001-04-10 Priority claimed from GB0108999A external-priority patent/GB0108999D0/en

2001-11-15 Priority claimed from GB0127426A external-priority patent/GB0127426D0/en

2003-09-29 Application filed by Pfizer Inc. filed Critical Pfizer Inc.

2005-08-31 Publication of HRP20030783A2 publication Critical patent/HRP20030783A2/hr

2011-11-30 Publication of HRP20030783B1 publication Critical patent/HRP20030783B1/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Virology (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
AIDS & HIV (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

HR20030783A 2001-04-10 2003-09-29 Pyrazole derivatives for treating hiv HRP20030783B1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB0108999A GB0108999D0 (en)	2001-04-10	2001-04-10	Pyrazole derivatives
GB0127426A GB0127426D0 (en)	2001-11-15	2001-11-15	Pyrazole derivatives
PCT/IB2002/001234 WO2002085860A1 (en)	2001-04-10	2002-04-04	Pyrazole derivatives for treating hiv

Publications (2)

Publication Number	Publication Date
HRP20030783A2 HRP20030783A2 (en)	2005-08-31
HRP20030783B1 true HRP20030783B1 (en)	2011-11-30

Family

ID=26245955

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HR20030783A HRP20030783B1 (en)	2001-04-10	2003-09-29	Pyrazole derivatives for treating hiv

Country Status (43)

Country	Link
US (4)	US7109228B2 (et)
EP (2)	EP1762567B1 (et)
JP (1)	JP3806090B2 (et)
KR (1)	KR100569324B1 (et)
CN (1)	CN100408564C (et)
AR (2)	AR037319A1 (et)
AT (2)	ATE358669T1 (et)
AU (1)	AU2002242926B2 (et)
BG (1)	BG66349B1 (et)
BR (1)	BRPI0208811B8 (et)
CA (1)	CA2443449C (et)
CR (1)	CR7069A (et)
CY (2)	CY1107626T1 (et)
CZ (1)	CZ305099B6 (et)
DE (1)	DE60219292T2 (et)
DK (2)	DK1377556T3 (et)
DO (1)	DOP2002000378A (et)
EA (1)	EA007184B1 (et)
EE (1)	EE05400B1 (et)
ES (2)	ES2385659T3 (et)
GE (1)	GEP20053619B (et)
HK (1)	HK1063781A1 (et)
HR (1)	HRP20030783B1 (et)
HU (1)	HU229025B1 (et)
IL (2)	IL157875A0 (et)
IS (1)	IS2734B (et)
MA (1)	MA27009A1 (et)
ME (1)	ME00558A (et)
MX (1)	MXPA03009380A (et)
MY (1)	MY146669A (et)
NO (1)	NO326518B1 (et)
NZ (1)	NZ529403A (et)
OA (1)	OA12501A (et)
PA (1)	PA8543601A1 (et)
PE (1)	PE20021056A1 (et)
PL (3)	PL217224B1 (et)
PT (2)	PT1762567E (et)
RS (1)	RS51166B (et)
SI (2)	SI1762567T1 (et)
SK (1)	SK287858B6 (et)
TW (1)	TWI333488B (et)
UY (1)	UY27248A1 (et)
WO (1)	WO2002085860A1 (et)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL217224B1 (pl) *	2001-04-10	2014-06-30	Pfizer	Kompozycja farmaceutyczna oraz jej zastosowanie
AU2002360818A1 (en) *	2001-12-28	2003-07-24	Bayer Pharmaceuticals Corporation	1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor
JP4228587B2 (ja) *	2002-05-22	2009-02-25	昭和電工株式会社	アミノメチル基含有ベンズアミド化合物の製造方法
GB0221477D0 (en) *	2002-09-16	2002-10-23	Pfizer Ltd	Chemical compounds
US20040132793A1 (en) *	2002-09-16	2004-07-08	Pfizer Inc.	Pyrazole derivatives
US6933312B2 (en)	2002-10-07	2005-08-23	Agouron Pharmaceuticals, Inc.	Pyrazole derivatives
GB0223234D0 (en) *	2002-10-07	2002-11-13	Pfizer Ltd	Chemical compounds
GB0223232D0 (en) *	2002-10-07	2002-11-13	Pfizer Ltd	Chemical compounds
TW200423930A (en) *	2003-02-18	2004-11-16	Hoffmann La Roche	Non-nucleoside reverse transcriptase inhibitors
WO2004085406A1 (en)	2003-03-24	2004-10-07	F. Hoffmann-La Roche Ag	Benzyl-pyridazinons as reverse transcriptase inhibitors
JP2006526017A (ja) *	2003-05-14	2006-11-16	サイトキネティクス・インコーポレーテッド	化合物、組成物および方法
US7220772B2 (en)	2003-09-05	2007-05-22	Pfizer, Inc.	Pyrazole derivatives
US7102001B2 (en) *	2003-12-12	2006-09-05	Bristol-Myers Squibb Company	Process for preparing pyrrolotriazine
WO2005080320A1 (en)	2004-02-13	2005-09-01	Warner-Lambert Company Llc	Androgen receptor modulators
CA2563291A1 (en)	2004-04-13	2005-10-27	Warner-Lambert Company Llc	4-cyano-phenoxy-alkyl carboxyl derivatives as androgen modulators
WO2005102990A1 (en)	2004-04-22	2005-11-03	Warner-Lambert Company Llc	Androgen modulators
AR048650A1 (es) *	2004-05-04	2006-05-10	Tibotec Pharm Ltd	Derivados de (1,10b-dihidro-2-(aminocarbonil-fenil)-5h-pirazolo[1,5 c][1,3]benzoxazin-5-il)fenil metanona como inhibidores de la replicacion viral del vih
WO2006006065A1 (en)	2004-07-08	2006-01-19	Warner-Lambert Company Llc	Androgen modulators
CA2604218A1 (en)	2005-04-20	2006-10-26	Pfizer Limited	Pyrazole derivatives as progesterone receptor antagonists
TW200724139A (en)	2005-05-05	2007-07-01	Warner Lambert Co	Androgen modulators
AR057455A1 (es) *	2005-07-22	2007-12-05	Merck & Co Inc	Inhibidores de la transcriptasa reversa de vih y composicion farmaceutica
BRPI0618630A2 (pt) *	2005-11-08	2011-09-06	Pfizer Ltd	compostos úteis em terapia, formulação farmacêutica que os contém, e seus usos
EP2010493B1 (en) *	2006-04-12	2016-01-27	Merck Sharp & Dohme Corp.	Pyridyl amide t-type calcium channel antagonists
CN101501002B (zh)	2006-08-16	2012-06-27	弗·哈夫曼-拉罗切有限公司	非核苷逆转录酶抑制剂
US20080096950A1 (en) *	2006-10-19	2008-04-24	Karl Richard Gibson	Compounds Useful In Therapy
US9280685B2 (en) *	2006-12-08	2016-03-08	Johnnie R. Jackson	System and method for portable medical records
WO2008135824A1 (en) *	2007-05-02	2008-11-13	Pfizer Limited	Oxyalkylpyrazole compounds useful in therapy
JP2010530863A (ja)	2007-06-22	2010-09-16	エフ．ホフマン−ラロシュアーゲー	非ヌクレオシド逆転写酵素阻害剤としての尿素及びカルバマート誘導体
CA2702126A1 (en) *	2007-10-24	2009-04-30	Merck Sharp & Dohme Corp.	Heterocycle amide t-type calcium channel antagonists
CA2701594C (en)	2007-10-24	2014-02-18	Merck Sharp & Dohme Corp.	Heterocycle phenyl amide t-type calcium channel antagonists
CA2709348C (en)	2007-12-21	2016-07-19	F. Hoffmann-La Roche Ag	Non-nucleoside reverse transcriptase inhibitors for treating human immunodeficiency virus (hiv-1) mediated diseases
EP3494972B1 (en)	2010-01-27	2023-12-13	VIIV Healthcare Company	Combinations of dolutegravir and lamivudine for the treatment of hiv infection
US8795310B2 (en) *	2010-04-13	2014-08-05	Sentreheart, Inc.	Methods and devices for accessing and delivering devices to a heart
CN103517990A (zh)	2010-10-07	2014-01-15	通用医疗公司	癌症生物标志物
JP5886310B2 (ja) *	2010-12-06	2016-03-16	グラクソグループリミテッドＧｌａｘｏＧｒｏｕｐＬｉｍｉｔｅｄ	Ｌｐ−ＰＬＡ２により媒介される疾患または状態の処置における使用のためのピリミジノン化合物
WO2013057593A1 (en)	2011-10-07	2013-04-25	Phivco Uk Limited	Process for the preparation of lersivirine
WO2013050873A1 (en)	2011-10-07	2013-04-11	Phivco Uk Limited	Process for the preparation of lersivirine
WO2013050884A1 (en)	2011-10-07	2013-04-11	Phivco Uk Limited	Process for the preparation of lersivirine
EP2716632A1 (en) *	2012-10-05	2014-04-09	Laboratoire Biodim	Inhibitors of viral replication, their process of preparation and their therapeutical uses
US9695127B2 (en)	2012-11-08	2017-07-04	University of Pittsburgh—of the Commonwealth System of Higher Education	Compounds for treating HIV and methods for using the compounds
US10026064B2 (en)	2013-09-13	2018-07-17	Microsoft Technology Licensing, Llc	Automatically recommending updates based on stored lifecycle information
US20160318933A1 (en) *	2013-10-23	2016-11-03	Sumitomo Dainippon Pharma Co., Ltd.	Fused pyrazole derivative
CN106458925A (zh) *	2014-05-06	2017-02-22	杜邦公司	杀真菌吡唑类
JP6626885B2 (ja) *	2014-10-31	2019-12-25	エフ．ホフマン−ラロシュアーゲーＦ．Ｈｏｆｆｍａｎｎ−ＬａＲｏｃｈｅＡｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ	新しいピリジニルオキシ及びフェニルオキシピラゾリル化合物
US9925190B2 (en)	2015-02-16	2018-03-27	University of Pittsburgh—of the Commonwealth System of Higher Education	Small molecules targeting HIV-1 Nef
JOP20180092A1 (ar) *	2017-10-13	2019-04-13	Gilead Sciences Inc	مثبطات hiv بروتياز
JP2021512956A (ja)	2018-02-06	2021-05-20	ザジェネラルホスピタルコーポレイション	腫瘍免疫応答のバイオマーカーとしてのリピートｒｎａ
KR102114389B1 (ko) *	2018-05-02	2020-05-25	이화여자대학교 산학협력단	신규 소듐채널 저해 화합물, 이의 제조방법, 및 이를 포함하는 소듐채널 관련 질환의 예방 또는 치료용 약학적 조성물
WO2020056564A1 (zh)	2018-09-17	2020-03-26	南通纺织丝绸产业技术研究院	基于金属氢化物/钯化合物体系制备1,3-二羰基化合物的方法
EP3868755A4 (en) *	2018-10-18	2022-05-25	Nanjing Sanhome Pharmaceutical Co., Ltd.	TGF-BETA R1 INHIBITOR COMPOUND AND USE THEREOF
CN113527306A (zh) *	2020-04-17	2021-10-22	南京圣和药物研发有限公司	喹啉类TGF-β1抑制剂的晶型
CN113527304A (zh) *	2020-04-17	2021-10-22	南京圣和药物研发有限公司	喹啉类TGF-β1抑制剂的制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3963742A (en) *	1974-07-12	1976-06-15	American Cyanamid Company	1,2-Dialkyl-3,4,5-trisubstituted pyrazolium salts as herbicidal agents

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3303200A (en) *	1963-11-05	1967-02-07	American Home Prod	Pyrazole-1-ethanol derivatives
US4009277A (en) *	1975-01-17	1977-02-22	American Cyanamid Company	1,2-Dialkyl-3,4,5-trisubstituted pyrazolium salts as fungicidal agents
US4041046A (en)	1975-06-06	1977-08-09	American Cyanamid Company	1,2-Dialkyl-3,4,5-trisubstituted pyrazole compounds
US4000301A (en)	1975-11-14	1976-12-28	American Cyanamid Company	Fungicidal use of 4-alkoxypyrazoles
US5376645A (en)	1990-01-23	1994-12-27	University Of Kansas	Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
KR0166088B1 (ko)	1990-01-23	1999-01-15	.	수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
JPH0565237A (ja)	1991-09-10	1993-03-19	Mitsubishi Heavy Ind Ltd	メタノールを媒体としたエネルギ供給方法
FR2682379B1 (fr)	1991-10-09	1994-02-11	Rhone Poulenc Agrochimie	Nouveaux phenylpyrazoles fongicides.
WO1994022830A1 (en)	1993-03-31	1994-10-13	Smithkline Beecham Corporation	Chemical compounds
FR2707295A1 (fr)	1993-06-07	1995-01-13	Rhone Poulenc Agrochimie	Fongicides pyrazoles substitués en position 3 par un hétérocycle.
EP0658547B1 (en)	1993-12-14	1998-03-11	Mitsubishi Chemical Corporation	N-pyrazolyl carbamate derivative, agricultural/horticultural fungicide containing the same as active ingredient and production intermediate thereof
FR2722369B1 (fr)	1994-07-13	1998-07-10	Rhone Poulenc Agrochimie	Compositions fongicides a base de derives 3-phenyl-pyrazoles pour le traitement du materiel vegetal de multiplication, nouveaux derives 3-phenyl-pyrazoles et leurs applications fongicides
EP0786455B1 (en)	1994-09-26	2003-12-03	Shionogi & Co., Ltd.	Imidazole derivative
TW343232B (en) *	1994-10-13	1998-10-21	Chisso Corp	Difluorooxymethane derivative and liquid crystal composition
GB9711643D0 (en)	1997-06-05	1997-07-30	Janssen Pharmaceutica Nv	Glass thermoplastic systems
IL152450A0 (en) *	2000-05-12	2003-05-29	Genzyme Corp	COMPOUNDS HAVING TNF-alpha SIGNAL MODULATING ACTIVITY
GB0016787D0 (en) *	2000-07-07	2000-08-30	Pfizer Ltd	Compounds useful in therapy
PL217224B1 (pl) *	2001-04-10	2014-06-30	Pfizer	Kompozycja farmaceutyczna oraz jej zastosowanie

2002
- 2002-04-04 PL PL396946A patent/PL217224B1/pl unknown
- 2002-04-04 CA CA002443449A patent/CA2443449C/en not_active Expired - Lifetime
- 2002-04-04 PL PL365026A patent/PL216985B1/pl unknown
- 2002-04-04 HU HU0303735A patent/HU229025B1/hu unknown
- 2002-04-04 KR KR1020037013352A patent/KR100569324B1/ko active IP Right Grant
- 2002-04-04 WO PCT/IB2002/001234 patent/WO2002085860A1/en active IP Right Grant
- 2002-04-04 AU AU2002242926A patent/AU2002242926B2/en not_active Expired
- 2002-04-04 EE EEP200300497A patent/EE05400B1/et unknown
- 2002-04-04 EP EP06126433A patent/EP1762567B1/en not_active Expired - Lifetime
- 2002-04-04 AT AT02708600T patent/ATE358669T1/de active
- 2002-04-04 CN CNB028116259A patent/CN100408564C/zh not_active Expired - Lifetime
- 2002-04-04 AT AT06126433T patent/ATE556059T1/de active
- 2002-04-04 GE GE5299A patent/GEP20053619B/en unknown
- 2002-04-04 ES ES06126433T patent/ES2385659T3/es not_active Expired - Lifetime
- 2002-04-04 ME MEP-758/08A patent/ME00558A/xx unknown
- 2002-04-04 DK DK02708600T patent/DK1377556T3/da active
- 2002-04-04 SK SK1244-2003A patent/SK287858B6/sk unknown
- 2002-04-04 IL IL15787502A patent/IL157875A0/xx unknown
- 2002-04-04 CZ CZ2003-2676A patent/CZ305099B6/cs not_active IP Right Cessation
- 2002-04-04 MX MXPA03009380A patent/MXPA03009380A/es active IP Right Grant
- 2002-04-04 SI SI200230986T patent/SI1762567T1/sl unknown
- 2002-04-04 NZ NZ529403A patent/NZ529403A/en not_active IP Right Cessation
- 2002-04-04 EA EA200300943A patent/EA007184B1/ru not_active IP Right Cessation
- 2002-04-04 PT PT06126433T patent/PT1762567E/pt unknown
- 2002-04-04 RS YUP-775/03A patent/RS51166B/sr unknown
- 2002-04-04 EP EP02708600A patent/EP1377556B1/en not_active Expired - Lifetime
- 2002-04-04 DE DE60219292T patent/DE60219292T2/de not_active Expired - Lifetime
- 2002-04-04 SI SI200230529T patent/SI1377556T1/sl unknown
- 2002-04-04 DK DK06126433.9T patent/DK1762567T3/da active
- 2002-04-04 ES ES02708600T patent/ES2283532T3/es not_active Expired - Lifetime
- 2002-04-04 PL PL398536A patent/PL217629B1/pl unknown
- 2002-04-04 PT PT02708600T patent/PT1377556E/pt unknown
- 2002-04-04 OA OA1200300258A patent/OA12501A/en unknown
- 2002-04-04 BR BRPI0208811-8 patent/BRPI0208811B8/pt not_active IP Right Cessation
- 2002-04-04 JP JP2002583387A patent/JP3806090B2/ja not_active Expired - Lifetime
- 2002-04-05 US US10/118,512 patent/US7109228B2/en not_active Expired - Lifetime
- 2002-04-08 MY MYPI20021264A patent/MY146669A/en unknown
- 2002-04-08 AR ARP020101281A patent/AR037319A1/es active IP Right Grant
- 2002-04-09 TW TW091107115A patent/TWI333488B/zh not_active IP Right Cessation
- 2002-04-09 UY UY27248A patent/UY27248A1/es not_active IP Right Cessation
- 2002-04-10 PA PA20028543601A patent/PA8543601A1/es unknown
- 2002-04-10 PE PE2002000297A patent/PE20021056A1/es active IP Right Grant
- 2002-04-10 DO DO2002000378A patent/DOP2002000378A/es unknown
2003
- 2003-09-04 IS IS6939A patent/IS2734B/is unknown
- 2003-09-09 CR CR7069A patent/CR7069A/es unknown
- 2003-09-11 IL IL157875A patent/IL157875A/en active IP Right Grant
- 2003-09-29 HR HR20030783A patent/HRP20030783B1/xx not_active IP Right Cessation
- 2003-10-06 MA MA27336A patent/MA27009A1/fr unknown
- 2003-10-08 BG BG108244A patent/BG66349B1/bg unknown
- 2003-10-09 NO NO20034523A patent/NO326518B1/no not_active IP Right Cessation
2004
- 2004-08-28 HK HK04106485A patent/HK1063781A1/xx not_active IP Right Cessation
2005
- 2005-06-20 US US11/157,340 patent/US7435728B2/en not_active Expired - Lifetime
2007
- 2007-05-10 CY CY20071100627T patent/CY1107626T1/el unknown
2008
- 2008-08-25 US US12/197,655 patent/US8063044B2/en not_active Expired - Fee Related
2010
- 2010-03-19 AR ARP100100890A patent/AR076259A2/es active IP Right Grant
2011
- 2011-10-07 US US13/269,278 patent/US20120029192A1/en not_active Abandoned
2012
- 2012-06-27 CY CY20121100571T patent/CY1113515T1/el unknown

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3963742A (en) *	1974-07-12	1976-06-15	American Cyanamid Company	1,2-Dialkyl-3,4,5-trisubstituted pyrazolium salts as herbicidal agents

Also Published As

Publication number	Publication date
JP2004531535A (ja)	2004-10-14
UY27248A1 (es)	2002-11-29
HK1063781A1 (en)	2005-01-14
CR7069A (es)	2007-12-17
ATE556059T1 (de)	2012-05-15
WO2002085860A1 (en)	2002-10-31
PT1762567E (pt)	2012-07-16
NZ529403A (en)	2005-06-24
IS6939A (is)	2003-09-04
CY1113515T1 (el)	2016-06-22
DOP2002000378A (es)	2002-10-15
BG66349B1 (bg)	2013-08-30
DE60219292T2 (de)	2008-04-10
SI1762567T1 (sl)	2012-08-31
EA200300943A1 (ru)	2004-08-26
KR100569324B1 (ko)	2006-04-07
KR20040007496A (ko)	2004-01-24
US20120029192A1 (en)	2012-02-02
BR0208811A (pt)	2004-03-09
BRPI0208811B8 (pt)	2021-05-25
EP1377556B1 (en)	2007-04-04
SI1377556T1 (sl)	2007-08-31
US20090215712A1 (en)	2009-08-27
CY1107626T1 (el)	2013-04-18
JP3806090B2 (ja)	2006-08-09
PL217224B1 (pl)	2014-06-30
ME00558A (en)	2011-12-20
MXPA03009380A (es)	2004-04-21
AR076259A2 (es)	2011-06-01
PT1377556E (pt)	2007-06-06
NO326518B1 (no)	2008-12-22
CN100408564C (zh)	2008-08-06
ATE358669T1 (de)	2007-04-15
DE60219292D1 (de)	2007-05-16
MY146669A (en)	2012-09-14
EA007184B1 (ru)	2006-08-25
AU2002242926B2 (en)	2007-10-11
YU77503A (sh)	2006-05-25
PL216985B1 (pl)	2014-06-30
BG108244A (bg)	2005-04-30
ES2283532T3 (es)	2007-11-01
HU229025B1 (en)	2013-07-29
US20030100554A1 (en)	2003-05-29
DK1762567T3 (da)	2012-06-25
IS2734B (is)	2011-04-15
HUP0303735A2 (hu)	2004-03-01
PL398536A1 (pl)	2012-06-04
HUP0303735A3 (en)	2004-07-28
PE20021056A1 (es)	2002-12-03
US8063044B2 (en)	2011-11-22
RS51166B (sr)	2010-10-31
EP1762567A1 (en)	2007-03-14
PL396946A1 (pl)	2012-01-02
BRPI0208811B1 (pt)	2018-03-13
IL157875A (en)	2010-05-17
EP1377556A1 (en)	2004-01-07
EP1762567B1 (en)	2012-05-02
CZ305099B6 (cs)	2015-05-06
IL157875A0 (en)	2004-03-28
CN1514828A (zh)	2004-07-21
DK1377556T3 (da)	2007-07-16
SK12442003A3 (sk)	2004-12-01
ES2385659T3 (es)	2012-07-27
EE05400B1 (et)	2011-04-15
NO20034523D0 (no)	2003-10-09
TWI333488B (en)	2010-11-21
HRP20030783A2 (en)	2005-08-31
MA27009A1 (fr)	2004-12-20
GEP20053619B (en)	2005-09-26
NO20034523L (no)	2003-12-09
PL365026A1 (en)	2004-12-27
US20060020012A1 (en)	2006-01-26
CZ20032676A3 (cs)	2004-11-10
CA2443449A1 (en)	2002-10-31
SK287858B6 (sk)	2012-01-04
OA12501A (en)	2006-05-26
US7435728B2 (en)	2008-10-14
US7109228B2 (en)	2006-09-19
EE200300497A (et)	2004-02-16
PA8543601A1 (es)	2002-10-31
CA2443449C (en)	2008-11-04
PL217629B1 (pl)	2014-08-29
AR037319A1 (es)	2004-11-03

Publication	Publication Date	Title
HRP20030783B1 (en)	2011-11-30	Pyrazole derivatives for treating hiv
AR033295A1 (es)	2003-12-10	Compuestos biciclicos de pirimidina, proceso para su obtencion, uso de los mismos para la preparacion de una composicion farmaceutica y dicha composicion farmaceutica
YU48390B (sh)	1998-07-10	Novi derivati 2-anilinopirimidina, postupak za njihovo dobijanje i sredstva za uništavanje štetočina, koja sadrže ove derivate
RS51937B (sr)	2012-02-29	Derivati heterociklokarboksamida
ES2190221T3 (es)	2003-07-16	Derivados de indol y su uso para el tratamiento de enfermedades malignas y otras, que se basan en proliferaciones celulares patologicas.
HRP20030791B1 (en)	2006-06-30	DIHYDRO-BENZO[b][1,4]DIAZEPIN-2-ONE DERIVATIVES AS mGluR2 ANTAGONISTS I
RS50118B (sr)	2009-03-25	Pirazolopirimidinoni koji inhibiraju tip 5 ciklične guanozin 3',5'-monofosfat fosfo-diesteraze (cgmp pde5) za tretman seksualne disfunkcije
RS51574B (sr)	2011-08-31	JEDINJENJA PIROLO (2,3-d) PIRIMIDINA
HRP20090005T3 (en)	2009-02-28	Bicyclic heterocycles as hiv integrase inhibitors
AR046711A1 (es)	2005-12-21	5-7-diaminopirazolo[4,3d]pirimidinas como inhibidores de la pde-5,composiciones farmaceuticas que las contienen y usos en el tratamiento de hipertensiones
NO20062032L (no)	2006-07-10	Derivater av N-[fenyl(pyrrolidin-2-yl)-metyl]benzamid og N-[(azepan-2-yl)fenylmetyl]benzamid, fremgangsmate for fremstilling derav og anvendelse derav i terapeutiske midler
HUP0300527A2 (hu)	2003-07-28	Pirrolopirimidinon-származékok, a vegyületek előállítása és alkalmazása
ES2062143T3 (es)	1994-12-16	Derivados de pirrol sustituidos con grupos acriloilo y procedimiento para su preparacion.
AR062499A1 (es)	2008-11-12	Derivados de n-fenil pirazol y piridil pirazoles, composiciones farmaceuticas que los contienen y usos como agentes antiagregantes plaquetarios y antitromboticos.
AR012622A1 (es)	2000-11-08	Inhibidores de proteasas, procedimiento para su preparacion, composicion farmaceutica que los comprende y el uso de los mismos en la fabricacion de unmedicamento
DE60235729D1 (de)	2010-04-29	1,8-Naphthyridine als CRF Antagonisten
DE69925472D1 (de)	2005-06-30	Benzoheterocyclische distamycinderivate, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel
DK190179A (da)	1979-11-13	Analogifremgangsmaade til fremstilling af neuroleptisk aktive xanthen-og thioxanthenderivater
RS51320B (sr)	2010-12-31	Derivati imidazohinolina kao veznici a3 receptora adenozina
CO5590961A2 (es)	2005-12-30	Compuestos de 2-pirimidona triciclica utiles como inhibidores de la transcriptasa inversa del vih
MXPA04004812A (es)	2004-08-11	Derivados de diazabiciclo alcano con actividad antagonistica de neurocinina.
PE20020708A1 (es)	2002-09-26	2-piridonas antimicrobianas, sus composiciones y usos
PE20020105A1 (es)	2002-02-21	Nuevo procedimiento para la preparacion de pirazolopirimidinonas
AR040139A1 (es)	2005-03-16	Camptotecinas con un anillo lactona modificado
ATE397609T1 (de)	2008-06-15	Corticotropinfreisetzungsfaktor antagonisten

Legal Events

Date	Code	Title	Description
2005-08-31	A1OB	Publication of a patent application
2006-02-28	ARAI	Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
2011-11-30	B1PR	Patent granted
2019-04-19	ODRP	Renewal fee for the maintenance of a patent	Payment date: 20190327 Year of fee payment: 18
2020-04-17	ODRP	Renewal fee for the maintenance of a patent	Payment date: 20200320 Year of fee payment: 19
2021-04-16	ODRP	Renewal fee for the maintenance of a patent	Payment date: 20210331 Year of fee payment: 20
2022-04-06	PB20	Patent expired after termination of 20 years	Effective date: 20220404